Cargando…
Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients
BACKGROUND: Pancreatic adenocarcinoma is one of the most lethal tumors in the world with a poor prognosis. Thus, an accurate prediction model, which identify patients within high risk of pancreatic adenocarcinoma is needed to adjust the treatment and elevate the prognosis of these patients. METHODS:...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503173/ https://www.ncbi.nlm.nih.gov/pubmed/37710166 http://dx.doi.org/10.1186/s12876-023-02916-y |